CTT PHARMACEUTICAL HOLDINGS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 8,300 | $0.06 | $498 | 7,845,956 | Dec 17, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | — | Purchase | 200,000 | $0.04 | $8,000 | 3,734,003 | Nov 20, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 62,900 | $0.04 | $2,516 | 7,837,656 | Nov 20, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 7,000 | $0.06 | $420 | 7,774,756 | Oct 31, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 6,815 | $0.06 | $409 | 7,767,756 | Sep 23, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Award / Grant | 750,000 | $0.04 | $30,000 | 7,716,856 | Aug 2, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 15,800 | $0.04 | $632 | 6,966,856 | Aug 1, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 8,000 | $0.03 | $240 | 6,951,056 | Jul 8, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 39,600 | $0.03 | $1,188 | 6,943,056 | Jun 26, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 16,100 | $0.03 | $483 | 6,903,456 | Jun 23, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Award / Grant | 150,000 | $0.06 | $9,000 | 6,750,400 | Jun 9, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 9,984 | $0.07 | $699 | 6,600,400 | Apr 9, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 15,510 | $0.05 | $776 | 6,590,416 | Mar 31, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 5,400 | $0.06 | $324 | 6,574,906 | Mar 11, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 11,950 | $0.09 | $1,076 | 6,569,506 | Mar 7, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 5,200 | $0.12 | $624 | 6,557,556 | Feb 5, 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 23,346 | $0.06 | $1,401 | 5,818,846 | Nov 25, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Award / Grant | 750,000 | $0.04 | $30,000 | 5,795,500 | Sep 11, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,100 | $0.06 | $66 | 5,044,750 | Sep 11, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 550 | $0.06 | $33 | 5,042,650 | Aug 27, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 2,900 | $0.05 | $145 | 5,042,100 | Aug 19, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,300 | $0.04 | $52 | 5,039,200 | Aug 12, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 2,200 | $0.04 | $88 | 5,037,900 | Aug 6, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,000 | $0.04 | $40 | 5,035,700 | Aug 5, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,000 | $0.06 | $60 | 5,043,650 | Aug 3, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,600 | $0.04 | $64 | 5,034,700 | Aug 1, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 3,100 | $0.04 | $124 | 5,033,100 | Jul 26, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,700 | $0.04 | $68 | 5,030,000 | Jul 24, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 2,000 | $0.05 | $100 | 5,028,300 | Jul 18, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,800 | $0.06 | $108 | 5,026,300 | Jul 16, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,070 | $0.06 | $64 | 5,024,500 | Jul 11, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 2,730 | $0.06 | $164 | 5,023,430 | Jul 11, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,454 | $0.06 | $87 | 5,020,700 | Jul 5, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,300 | $0.06 | $78 | 5,019,246 | Jun 25, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,000 | $0.07 | $70 | 5,017,946 | Jun 20, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 54,798 | $0.03 | $1,644 | 6,887,356 | Jun 13, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Award / Grant | 86,956 | $0.03 | $2,609 | 5,016,946 | Jun 12, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 1,990 | $0.05 | $100 | 4,929,990 | Jun 11, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 7,376 | $0.02 | $148 | 4,158,000 | Jun 3, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 3,236 | $0.03 | $97 | 4,150,624 | May 21, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 9,500 | $0.04 | $380 | 4,167,388 | May 7, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 4,388 | $0.03 | $132 | 4,157,888 | May 2, 2024 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 8,700 | $0.02 | $174 | 883,500 | Mar 27, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Award / Grant | 500,000 | $0.02 | $10,000 | 1,383,500 | Mar 20, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 3,840 | $0.04 | $154 | 874,800 | Mar 3, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 4,960 | $0.04 | $198 | 870,960 | Feb 8, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 9,000 | $0.03 | $270 | 866,000 | Jan 30, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 61,695 | $0.02 | $1,234 | 857,000 | Jan 25, 2023 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 500,000 | $0.02 | $10,000 | 1,883,500 | Aug 18, 2022 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 500,000 | $0.02 | $10,000 | 2,383,500 | Feb 18, 2022 |